Chemotherapy Without Acute Leukemia As Secondary Diagnosis with Mcc in Nevada
MS-DRG 846: Chemotherapy without acute leukemia as secondary diagnosis with mcc
Billed (list price)Actually paid (Medicare + patient)
| Hospital | City | Medicare stays | Billed | Paid | Cash price | Insurers (median) | |
|---|---|---|---|---|---|---|---|
| Sunrise Hospital and Medical Center | Las Vegas | – | – | – | – | $12,648$3,057–$37,742 · 35 plans |
Medicare: CMS, 2024 (hospitals with 11 or more Medicare stays). Cash and insurer prices: hospitals' own price files, where read; insurer figures are commercial plans only, median and 10th–90th percentile across plans.